Experts say fast-spreading, less severe profile of Omicron is emerging as cases drop in South Africa but warn of challenging weeks ahead.

Love, death, fear, guilt, pride, hope, friendship, alienation, and so much sorrow. Through it all, they kept showing up.

Harvard-led research signals life-saving potential for artificial intelligence in fight against colon cancer.

Dan Barouch, Harvard Medical School professor and head of Beth Israel Deaconess’ Center for Virology and Vaccine Research, was awarded Harvard’s George Ledlie Prize for work that culminated in one of three vaccines against COVID-19 approved for use in the U.S.

Single-shot COVID-19 vaccine generates robust immune responses against variants.

As the pandemic reaches what experts hope will be its latter stages, the health care system is seeing more “long COVID” patients, those whose often mild initial illness has been followed up by months of severe, sometimes debilitating symptoms. The Gazette spoke with an expert to find out more.

With new coronavirus variants on the U.S. pandemic scene, experts say brace yourself for another surge — and mask up.

Harvard Medical School Professor Dan Barouch said the “complicated pandemic” means more work lies ahead.

A new trial at Beth Israel Deaconess Medical Center is aiming to disrupt COVID-19’s attack early in its course by treating patients immediately after symptoms appear with a widely used antiviral drug that, if it works, could be rapidly repurposed to fight the coronavirus.

BIDMC-led research team reports vaccine protection against severe COVID-19-related pneumonia and death.